Blood markers and progression in progressive multiple sclerosis
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study measures specific proteins in your blood that may help doctors understand how progressive multiple sclerosis advances. By tracking these markers over time, researchers hope to better predict disease progression and improve treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of multiple sclerosis (MS)
- Your MS is the progressive type (symptoms gradually worsen over time)
- You are between 18 and 60 years old
- Your disability level is significant (EDSS score of 5.5 or higher, meaning you need mobility aids)
- You have not started or changed MS medications in the past 3 months
- You have not had an MS relapse (sudden worsening) in the past 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is studying how multiple sclerosis (MS) progresses over time. It may help researchers understand the disease better.
This study looks at genetic information and blood test signals to understand why some people with early MS develop a worse outcome. It may help doctors predict who is at higher risk and better understand disease mechanisms.
This study measures blood markers (from a serum blood sample) to see how nerve and brain changes relate to MS disease activity and disability over time. It may help researchers better monitor MS, especially in people followed in the OFSEP program.
This study is looking for people with MS who are already on a monoclonal antibody therapy. It aims to measure subtle signs of disease progression using advanced tests, even if you feel stable.
This study looks at small particles in your blood called extracellular vesicles. They may show how much nerve damage has happened in multiple sclerosis or after a stroke. The goal is to find a simple blood test that could help track these conditions.
This study looks for signs of “synapse damage” in multiple sclerosis using blood tests and brain imaging (MRI). The goal is to find biomarkers that may help better understand MS and how it changes over time.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.